Most prostate cancers are androgen-dependent (with androgen receptor (AR) expression) adenocarcinomas, which possess a glandular formation, and can produce prostate-specific antigen (PSA) under the regulation of AR activity. Here, KLK3 is linked to adenocarcinoma.